Stoke Therapeutics Inc buy Needham & Company LLC
Start price
26.03.24
/
50%
€9.30
Target price
26.03.25
€20.27
Performance (%)
15.05%
Price
22.04.24
€10.60
Summary
This prediction is currently active. The prediction currently has a performance of 15.05%. This prediction currently runs until 26.03.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -3.636% | -3.636% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Needham___Company_LL for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its price target raised by analysts at Needham & Company LLC from $14.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€12.00
11.04.24
11.04.24
€20.48
11.04.25
11.04.25
-13.33%
22.04.24
22.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€4.86
16.02.24
16.02.24
€13.02
16.02.25
16.02.25
113.99%
22.04.24
22.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€4.46
07.11.23
07.11.23
€13.09
07.11.24
07.11.24
139.91%
22.04.24
22.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€5.20
07.08.23
07.08.23
€22.72
07.08.24
07.08.24
105.77%
22.04.24
22.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.60
08.03.23
08.03.23
€23.71
08.03.24
08.03.24
-20.93%
09.03.24
09.03.24